Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:41197SL/Kh is an inbred strains exhibiting high incidence of spontaneous pre-B lymphomas and AKR/JMs is an inbred strain exhibiting high incidence of T-lymphomas. A recessive allele in SL/Kh mice shortened the development of lymphomas and was shown to be dependent on H2 haplotypes. 114 (AKR/JMs x SL/Kh)F2 mice were analyzed for the segregation of the shortened latency phenotype (lla) as a quantitative trait. The results from the F2 cross show that the lla phenotype was significantly associated with H2 class II loci with a maximal LOD score of 7.06. J:33016Linkage analysis was performed on 114 animals from a (SL/Kh x AKR/JMs)F2 intercross to identify loci associated with lymphoma susceptibility. F2 mice were generated by mating reciprocal F1 hybreds bewteen SL/Kh and AKR/Ms. 45 polymorphic markers covering 67% of the mouse genome were used in the analysis. A locus named Tlsm1 (thymic lymphoma susceptibility 1) mapped to 60 cM mouse Chromosome 7 near D7Mit8. AKR/JMs-derived alleles at Tlsm1 confer susceptibility to thymic lymphomas with a dominant mode of inheritance.An SL/Kh-derived recessive locus at 18.6 cM on mouse Chromosome 17 near D17Mit21 was found to accelerate the latency period of all types of lymphomas (LOD=7.06). This locus is named lla (lymphoma latency acceleration.) lla overlaps with the H2 locus. |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|